title,text,authors,publish_time,url
Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics, Clinical trials on highrisk cardiovascular patients have demonstrated their efficacy in reducing LDL-C,"Khoshnejad, Makan; Patel, Ami; Wojtak, Krzysztof; Kudchodkar, Sagar B.; Humeau, Laurent; Lyssenko, Nicholas N.; Rader, Daniel J.; Muthumani, Kar; Weiner, David B.",2019-01-02,https://doi.org/10.1016/j.ymthe.2018.10.016
Antibody therapies for the prevention and treatment of viral infections," Although no dengue antibody therapeutics have reached the stage of clinical trials, some of Antibody therapies for viral infections G Salazar et al","Salazar, Georgina; Zhang, Ningyan; Fu, Tong-Ming; An, Zhiqiang",2017-07-10,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627241/
Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis,We initiated this study to determine whether anti-inflammatory and antiviral therapy control acute CHIKV arthritis in mice,"Miner, Jonathan J.; Cook, Lindsey E.; Hong, Jun P.; Smith, Amber M.; Richner, Justin M.; Shimak, Raeann M.; Young, Alissa R.; Monte, Kristen; Poddar, Subhajit; Crowe, James E.; Lenschow, Deborah J.; Diamond, Michael S.",2017-02-01,http://europepmc.org/articles/pmc5448557?pdf=render
Protective Efficacy of Passive Immunization with Monoclonal Antibodies in Animal Models of H5N1 Highly Pathogenic Avian Influenza Virus Infection,Current strategies for the control of influenza include vaccination and antiviral drug treatment,"Itoh, Yasushi; Yoshida, Reiko; Shichinohe, Shintaro; Higuchi, Megumi; Ishigaki, Hirohito; Nakayama, Misako; Pham, Van Loi; Ishida, Hideaki; Kitano, Mitsutaka; Arikata, Masahiko; Kitagawa, Naoko; Mitsuishi, Yachiyo; Ogasawara, Kazumasa; Tsuchiya, Hideaki; Hiono, Takahiro; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Kida, Hiroshi; Ito, Mutsumi; Quynh Mai, Le; Kawaoka, Yoshihiro; Miyamoto, Hiroko; Ishijima, Mari; Igarashi, Manabu; Suzuki, Yasuhiko; Takada, Ayato",2014-06-12,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055766/
New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets,"In the absence of reliable antiviral drugs and vaccines, development of alternative strategies for influenza prophylaxis and therapy is urgently required","Friesen, Robert H. E.; Koudstaal, Wouter; Koldijk, Martin H.; Weverling, Gerrit Jan; Brakenhoff, Just P. J.; Lenting, Peter J.; Stittelaar, Koert J.; Osterhaus, Albert D. M. E.; Kompier, Ronald; Goudsmit, Jaap",2010-02-08,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817000/
Therapeutic Applications of Monoclonal Antibodies, Many physicians use a combination of antiviral agents and immunoglobulins in patients at risk for CMV infection,"Berger, Mitchell; Shankar, Vidya; Vafai, Abbas",2002-07-31,https://doi.org/10.1097/00000441-200207000-00004
